81 FR 38195 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 113 (June 13, 2016)

Page Range		38195-38195
FR Document		2016-13828

Federal Register, Volume 81 Issue 113 (Monday, June 13, 2016)

[Federal Register Volume 81, Number 113 (Monday, June 13, 2016)]
[Notices]
[Page 38195]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-13828]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; RFA DK15-030 Type 1 
Diabetes Pathfinder Award (DP2).
    Date: July 14, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Ann A. Jerkins, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7119, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, 301-
594-2242, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; NIDDK Program Projects 
(P01).
    Date: July 22, 2016.
    Time: 2:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Jason D. Hoffert, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7343, 6707 Democracy Boulevard, Bethesda, MD 20817, 301-496-
9010, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Minor Endoscopic 
Sphincterotomy for Recurrent Acute Pancreatitis with Pancreas 
Divisum.
    Date: July 25, 2016.
    Time: 2:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Paul A. Rushing, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7345, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-8895, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Psychological and 
Behavioral Mechanisms in Bariatric Surgery (R01).
    Date: July 26, 2016.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Paul A. Rushing, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7345, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-8895, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: June 6, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-13828 Filed 6-10-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 113 / Monday, June 13, 2016 / Notices 38195

• Tell NIDA how you design entries will be scored in accordance Place: National Institutes of Health, Two
scientific experiments in general. with the judging criteria outlined above. Democracy Plaza, 6707 Democracy
Amount of the Prize; Award Final recommendations will be Boulevard, Bethesda, MD 20892 (Telephone
Approving Official. Up to ten monetary Conference Call).
determined by a vote of the judges based
Contact Person: Jason D. Hoffert, Ph.D.,
prizes will be awarded. The total prize on score. Scores from each criterion will Scientific Review Officer, Review Branch,
award pool is up to $100,000. No be weighted equally, but failure to meet DEA, NIDDK, National Institutes of Health,
institutional indirect costs are allowed. a minimum standard for any one Room 7343, 6707 Democracy Boulevard,
The names of the winners and the titles criterion might disqualify a submission. Bethesda, MD 20817, 301–496–9010,
of their submissions will be posted on The score for each submission will be hoffertj@niddk.nih.gov.
the NIDA Web site. The award the sum of the scores from each of the Name of Committee: National Institute of
approving official for this Challenge is voting judges. Diabetes and Digestive and Kidney Diseases
the Director of the National Institute on Special Emphasis Panel; Minor Endoscopic
Authority: 15 U.S.C. 3719 Sphincterotomy for Recurrent Acute
Drug Abuse.
Payment of the Prize. Prizes awarded Dated: June 7, 2016. Pancreatitis with Pancreas Divisum.
under this Challenge will be paid by Nora D. Volkow, Date: July 25, 2016.
Time: 2:00 p.m. to 3:00 p.m.
electronic funds transfer and may be Director, National Institute on Drug Abuse,
Agenda: To review and evaluate grant
subject to Federal income taxes. The National Institutes of Health.
applications.
NIH/NIDA will comply with the [FR Doc. 2016–13936 Filed 6–10–16; 8:45 am] Place: National Institutes of Health, Two
Internal Revenue Service withholding BILLING CODE 4140–01–P Democracy Plaza, 6707 Democracy
and reporting requirements, where Boulevard, Bethesda, MD 20892 (Telephone
applicable. Conference Call).
Basis upon Which the Winner Will Be DEPARTMENT OF HEALTH AND Contact Person: Paul A. Rushing, Ph.D.,
Selected. The judging panel will make HUMAN SERVICES Scientific Review Officer, Review Branch,
recommendations to the award DEA, NIDDK, National Institutes of Health,
National Institutes of Health Room 7345, 6707 Democracy Boulevard,
approving official based upon the Bethesda, MD 20892–5452, (301) 594–8895,
following 5 criteria. Each criterion will rushingp@extra.niddk.nih.gov.
be scored with the maximum of 10 National Institute of Diabetes and
Digestive and Kidney Diseases; Notice Name of Committee: National Institute of
points. Diabetes and Digestive and Kidney Diseases
(1) Significance and Unmet Needs (0– of Closed Meetings
Special Emphasis Panel; Psychological and
10 points). Are there significant needs Pursuant to section 10(d) of the Behavioral Mechanisms in Bariatric Surgery
for your product or service? Does the Federal Advisory Committee Act, as (R01).
project address an important problem or amended (5 U.S.C. App.), notice is Date: July 26, 2016.
a critical barrier to progress in the field Time: 1:00 p.m. to 5:00 p.m.
hereby given of the following meetings. Agenda: To review and evaluate grant
of drug abuse research? If the aims of The meetings will be closed to the
the project are achieved, how will applications.
public in accordance with the Place: National Institutes of Health, Two
scientific knowledge, technical provisions set forth in sections Democracy Plaza, 6707 Democracy
capability, service or clinical practice be 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Boulevard, Bethesda, MD 20892 (Telephone
improved? as amended. The grant applications and Conference Call).
(2) Innovation (0–10 points). Does the Contact Person: Paul A. Rushing, Ph.D.,
the discussions could disclose
submission seek to shift current Scientific Review Officer, Review Branch,
confidential trade secrets or commercial
paradigms by utilizing novel theoretical DEA, NIDDK, National Institutes of Health,
property such as patentable material, Room 7345, 6707 Democracy Boulevard,
concepts, approaches, methodologies,
and personal information concerning Bethesda, MD 20892–5452, (301) 594–8895,
instrumentation, service or
individuals associated with the grant rushingp@extra.niddk.nih.gov.
interventions for drug abuse research? Is
applications, the disclosure of which (Catalogue of Federal Domestic Assistance
your product novel in a broad sense? Is
would constitute a clearly unwarranted Program Nos. 93.847, Diabetes,
a refinement, improvement or new
invasion of personal privacy. Endocrinology and Metabolic Research;
application of theoretical concepts, 93.848, Digestive Diseases and Nutrition
approaches or methodologies Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases Research; 93.849, Kidney Diseases, Urology
instrumentation or interventions and Hematology Research, National Institutes
Special Emphasis Panel; RFA DK15–030
proposed? of Health, HHS)
Type 1 Diabetes Pathfinder Award (DP2).
(3) Approach (0–10 points). Are the
Date: July 14, 2016. Dated: June 6, 2016.
overall strategy, methodology, and Time: 8:00 a.m. to 5:00 p.m. David Clary,
analyses well-reasoned and appropriate Agenda: To review and evaluate grant
to test the proposed idea? Has feedback Program Analyst, Office of Federal Advisory
applications.
Committee Policy.
from end users been incorporated into Place: Residence Inn Bethesda, 7335
the validity of the idea proposed? Wisconsin Avenue, Bethesda, MD 20814. [FR Doc. 2016–13828 Filed 6–10–16; 8:45 am]
(4) Team expertise (0–10 points). Does Contact Person: Ann A. Jerkins, Ph.D., BILLING CODE 4140–01–P
the individual or team demonstrate high Scientific Review Officer, Review Branch,
level of ability, perseverance and grit? DEA, NIDDK, National Institutes of Health,
(5) Commercialization (0–10 points). Room 7119, 6707 Democracy Boulevard, DEPARTMENT OF HEALTH AND
Is there a clear path for the product/ Bethesda, MD 20892–5452, 301–594–2242, HUMAN SERVICES
jerkinsa@niddk.nih.gov.
service to reach the market? Are the
srobinson on DSK5SPTVN1PROD with NOTICES

product users and purchasers clearly Name of Committee: National Institute of National Institutes of Health
Diabetes and Digestive and Kidney Diseases
identified? Special Emphasis Panel; NIDDK Program Center for Scientific Review; Notice of
Submissions that are responsive and Projects (P01). Closed Meetings
comply with the entry requirements will Date: July 22, 2016.
be reviewed by a panel of judges Time: 2:00 p.m. to 4:00 p.m. Pursuant to section 10(d) of the
consisting of federal employees. The Agenda: To review and evaluate grant Federal Advisory Committee Act, as
responsive and compliant submissions applications. amended (5 U.S.C. App.), notice is

VerDate Sep<11>2014 20:48 Jun 10, 2016 Jkt 238001 PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 E:\FR\FM\13JNN1.SGM 13JNN1

Document Created: 2018-02-08 07:39:33
Document Modified: 2018-02-08 07:39:33

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		July 14, 2016.
FR Citation		81 FR 38195

81 FR 38195 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 113 (June 13, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health